Economy

Amicus (FOLD) Flies to 52-Week High on $5-Billion BioMarin Merger

Amicus Therapeutics, Inc. (NASDAQ:FOLD) made headlines on Friday as it soared to a new 52-week high, closing at $14.18 per share. This significant jump of 30.21 percent was fueled by

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Japan to court Tesla on Nissan investment

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter.

The King of New York

During Joe Biden's presidency, Republicans voiced their concerns about the abuse of power, particularly when it came to issues like

Startup Together AI Valued at $3.3 Billion as AI Demand Grows

Together AI, a startup that offers access to artificial intelligence computing, has successfully raised $305 million in a recent funding

The Benefits of Free Trade Are at Risk

As a former economics professor at the Naval Postgraduate School, I always emphasized the importance of comparative advantage to my

Treasury sets new deadline for businesses to report ownership information

The deadline for millions of businesses to report their "beneficial ownership information" has been extended to March 21 by the

European stocks outpace Wall Street since Donald Trump took office

Unlock the White House Watch newsletter for free Your guide to what the 2024 US election means for Washington and

Short sellers lose $73 billion amid market rally to start 2025

Stock market short sellers have had a rough start to 2025, with losses totaling $73 billion in the US and

Revealed preference as an analytical tool

Economists often rely on the concept of "revealed preference" to understand people's beliefs through their actual behavior. This approach has